IL-33 in Rheumatic Diseases.

IL-33 in Rheumatic Diseases.
复制标题

IL-33 在风湿性疾病中的作用

DOI:
10.3389/fmed.2021.739489
复制
发表时间:
2021
影响因子:
3.9
通讯作者:
Dong L
Dong L
中科院分区:
医学3区
文献类型:
--
作者:
Dong Y;Zhong J;Dong L

文献摘要

参考文献

被引文献

相似文献

白细胞介素-33(IL-33)是一种核因子,主要表达于屏障上皮细胞、内皮细胞和成纤维网状细胞。一些炎性细胞在某些条件下也表达IL-33。近年来,IL-33在过敏反应、蠕虫感染、癌症、组织纤维化、慢性炎症、器官移植和风湿性免疫疾病中的重要作用已被广泛研究。IL-33主要激活各种循环和组织驻留免疫细胞,包括肥大细胞、第2组先天性淋巴样细胞(ILC 2)、调节性T细胞(Treg)、T辅助细胞2(Th 2)、自然杀伤细胞(NK细胞)和巨噬细胞。因此,IL-33在不同的免疫微环境中发挥免疫调节作用并显示多效性。IL-33/血清刺激-2(ST 2)轴已被证明对类风湿性关节炎、系统性红斑狼疮和其他风湿性疾病具有有害作用。有趣的是,IL-33还在屏障上皮的修复和TGFAP的激活中起保护作用。因此,IL-33/ST 2的作用取决于风湿性疾病的基础病理条件。本文综述了IL-33/ST 2轴在风湿性疾病中的双重作用。
Interleukin-33 (IL-33) is a nuclear factor mainly expressed in barrier epithelium, endothelial cells, and fibroblast reticular cells. Some inflammatory cells also express IL-33 under certain conditions. The important role of IL-33 in allergic reactions, helminth infection, cancer, tissue fibrosis, chronic inflammation, organ transplantation, and rheumatic immune diseases has been extensively studied in recent years. IL-33 primarily activates various circulating and tissue-resident immune cells, including mast cell, group 2 innate lymphoid cell (ILC2), regulatory T cell (Treg), T helper 2 cell (Th2), natural killer cell (NK cell), and macrophage. Therefore, IL-33 plays an immunomodulatory role and shows pleiotropic activity in different immune microenvironments. The IL-33/serum stimulation-2 (ST2) axis has been shown to have a detrimental effect on rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic diseases. Interestingly, IL-33 also plays a protective role in the repair of barrier epithelium and the activation of Tregs. Therefore, the role of IL-33/ST2 depends on the underlying pathological conditions in rheumatic diseases. This review focuses on the dual role of the IL-33/ST2 axis in rheumatic diseases.
DOI: 10.1073/pnas.0812690106
发表时间: 2009-06-02
影响因子: 11.1
作者:
Cayrol, Corinne;Girard, Jean-Philippe
通讯作者: Girard, Jean-Philippe
DOI: 10.7554/elife.65614
发表时间: 2021-04-30
期刊: eLife
影响因子: 7.7
作者:
Clark JT;Christian DA;Gullicksrud JA;Perry JA;Park J;Jacquet M;Tarrant JC;Radaelli E;Silver J;Hunter CA
通讯作者: Hunter CA
DOI: 10.1038/cmi.2016.34
发表时间: 2017-01
影响因子: 24.1
作者:
通讯作者: --
DOI: 10.1038/nrdp.2016.47
发表时间: 2016-07-07
影响因子: 81.5
作者:
Brito-Zeron, Pilar;Baldini, Chiara;Ramos-Casals, Manuel
通讯作者: Ramos-Casals, Manuel
DOI: 10.1007/s00011-020-01399-x
发表时间: 2020-09-04
影响因子: 6.7
作者:
Fattori, Victor;Staurengo-Ferrari, Larissa;Verri Jr, Waldiceu A.
通讯作者: Verri Jr, Waldiceu A.